 Yng Nghymru, mae'n gweithio o'ch byddhef, y fwy ffyniad 50 o'ch bydd hefyd yn gweithio'r bwysig ac mae'r ddau'r cyflwr yw'r ddau'r ddau ffyniad. Rwy'n gweithio'n gweithio, rwy'n gweithio'r busin yma, mae'r businid yn y gweithio ar gael a'r bwysig. Rwy'n gweithio'r ddau'r bwysig yma, ond mae'n gyfrifiad y maen nhw i'n meddwl ar yr oed, a dwi'n gweithio'n gweithio'r bwysig. Rhaid i'w berthynas yn hynny'r bod hynny'n ffordd, oherwydd mae'n gorfod am yr ydym ni'n edrych. Felly, y gallwn gwneud hynny'r hyn yn gwybod ar gyfer, ddyn nhw'n ddwy'r cyfnod, oherwydd dod yn ddweud â'r cyfrifiadol ar gwell. Felly, y ddyn nhw yma. Felly, y ddyn nhw yw ymwneud yn cyffryd cyllidol, C-U-C-P, yn y cyfrifiadol ar gael i'w ddyn nhw. Ie, rydyn ni? felly mae'r wylio gyda'r hwn o bobl yn brifoedd ydym ni. Felly mae'n bwysig yn bwysig yn bwysig yn bwysig yng nghylchau'n bwysig yng Nghyrch Cymru. Cysylltu'n bwysig yn bwysig. Mae'n gwybod hir o'r hyn yno o'r hyn o hyn yn dweud yn bwysig, felly mae'n bwysig, mae'n bwysig, oherwydd mae'n bwysig. Yn ystod, mae'n gwybod hwn o'r hyn o'r holl yng Nghyrch Cymru, mae mor masau ar hyn o hyn yn cael ei wneud o gwneud o'r masydydyddio yn ni. Ond mae'r potensial yn cael ei masydyddio yn eich syddstyeth iawn yn i gael busnes hanesolfo, ond mae'r bwysig ffawr bod yn ni'n gwybod cael gw While N Cao, a'n gwneud yw hefyd yn cael ei gael ei wneud. Fyn wedi bod a'r dda, mae'n gweithio'r cyffredin ni hynny. Yn gyfrifio'r cyfrifio, mae'n cyfrifio'r cyfrifio, y llyfrifio'r cyfrifio hynny yw y llif o'r $4.50, a medium of $4.75 a high of $5 in the next 12 months. The price is currently set at $2.14. Another interesting point about this stock is that institutional investors and investor firms are continuously buying this stock, which tells me that this stock does have some potential because these institutional investors they have a lot of research facilities. They can research into the information. They've got researchers that help make their stock picks, right? And they see potential in this stock. So that gives me kind of comfort knowing that they see potential in it. And it's only at $2.14 based upon the actual current forecast here. It may be set to go double, okay? But I think that actually maybe it could go further because of the areas that it's involved with. So I think that this is one to have in your potential watch list for a dip and then buying in or potentially starting a small positioning because I do think it's going to run up. It's got a lot of credibility as well in terms of because it's got those institutional investors involved. So it's called Cochristor Pharma. The ticker symbol is CP. So check that one out and see what you think. The next one I've got for you is called Inuva INUV. And I actually really like this stock. I think I am going to hold on to this for certainly the medium to long term because I think this is just the tip of what is available for this stock in terms of the amount that it can go up by. Things can go into go much further because it's a good business. If you look at the information about this stock it's a really good business, I think. And we've got the business description here. So what is it? So it's a market leader in intelligent advertising aligning brands with appropriate content and consumer intent. The artificial intelligence with our patented intent key leverages contextually based machine learning that mirrors the manner in which the human brain can instantly associate ideas, emotions, places, people and objects. Inuva harnesses the power by delivering high performing campaigns reaching audiences that would typically be missed. But much like I talked about the other stock and also this stock, I have made a full video on this stock where we go down in depth. So do check out some of our previous videos on this. But one of the main points for this stock is that they actually increase the click-through rates in advertisement campaigns because they're able to reach direct to the target markets more and there are a marketing company that's able to do this. It's also very AI driven as well. So it's actually helping businesses and they work with really big businesses as well. They've got partnerships with really big businesses. It's helping them making sure that they get in their monies where from their advertising, which is really important. Now this is a massive industry. It's a billion billion billion dollar industry marketing and advertising in itself, right? And the thing is the marketing spend, marketing budget has been cut in a lot of companies. Why? It's been cut in a lot of companies because of the current situation. And there's a lot of companies that aren't actually spending as much on marketing as they was. Now, as we come back to a bit more normality, I think that potentially the market spend is going to go up because people are going to be advertising more companies are. And then this particular company stands to benefit. We've heard ARC talk about this. We've heard ARC talk about the facts that consumer spending habits are going to be quite large because of the facts that people have got savings and people have saved up money and the consumer spending is going to just increase combined with the fact that obviously there's going to be more marketing spend that matches that consumer spending as well, okay? So I think that this is going to be a good stock. By the way, I cannot invest in this. I'm just drawing some parallels, okay? I'm looking at the context of the overall stock and the environment of it and the potential of the stock itself, okay? So Inuva, what are they selling? They're selling $1.89, okay? I think that this can reach $2.53 very easily, okay? And I think that this is a medium to long-term hold. It's got a lot of potential. If they can keep growing and I think, again, their revenue is going to grow particularly in months as we get back to sort of more normality, right? So that's Inuva. Before we move on to the next stocks, I've got to say thank you for everybody who subscribed recently. Our channel is growing massively. We've gained 1,000 subscribers almost in what essentially is a day. 1,000 subscribers in a day. You know, this is massive. And so the channel is being growing massively. So thank you for all the support. So keep liking the videos. Keep sharing them and keep subscribing. I really do appreciate that. I'm really trying to grow this to 10,000 subscribers as fast as we possibly can. So any help you can offer would be greatly appreciated in that journey. Moving on. Let's move it on. Back to more stocks. The next one I've got for you is Bantech Inc. Take a symbol B-A-N-T. Now with this one, I've got to say be careful to begin with. This is a stock. So I have my medium-term stocks. I have my long-term penny stocks. This stock, it does have some potential and I think it's got potential to run up particularly for this Drone USA area. But their balance sheet isn't great. And I want to be honest, I don't want to hype up stocks. The balance sheet isn't great. What they've got, Bantech, right? But I think that this is a get-in and get-out play. I think you could make 60, 70% up to potentially 200% on this stock in the short term and just get buy-in, set your own price target, your own strategy with that and sell and do a quick flip on this stock. I think that there's a potential to do this. Now, who are they? You can see by here they've got Bantech online store which sells sanitising products and robots to help combat that. Then you've got Howcur Distribution. Distributing this company is established in 1990 with the mission of being a leading and respected provider of construction, transportation, mining and heavy equipment, spare and replacement parts. They've also got a construction division as well down here. But also, they've got this area which I'm very much interested in, which why I think there's going to be a lot of investor sentiment based around this one because we've seen UAV, we've seen a lot of these drone stocks absolutely explode exponentially. And if this can just do even just an absolute mini, miniscule fraction of what they've done, then there's going to be money to be made in this. But that, again, I'm not happy fully with this stock because of the balance sheet. But look at this. Drone USA helps customers with a drone selection process making sure that the technology and accessories are the perfect fit tailored to their specific needs ensures process of implementing drone technology. They also do drone training courses and drone training, educational in relation to drones. So I think that this might run up a little bit or maybe quite a lot actually, but I think that it could equally run down just afterwards that it's going to be one of those stocks. Okay, so I actually put a small position in this stock to see what it does at, but I am having intention to take a profit. I'm not holding this medium to long. You know, it does have potential, right? So if you want to hold this medium to long, go for it. But for me, it's a get in and get out play, invest, wait for it to run up a little bit, then get out and take your profit. Sometimes with penny stocks, they can't all be medium to long. Sometimes it's just about getting that swing train. And I think that this is one of them based upon potential investor sentiment around this drone area, okay? Now we can see here the current price. It's at 0.019, okay? And let's say I'm looking for a double up on this stock and then I'll be selling my small position. So I'm looking for a double up or maybe triple and then that's what I'll do, okay? That's what my strategy is. You can obviously decide whether you want to do the same strategy or you want to do a different one, but obviously do your own research. I'm not a financial advisor. The next one I've got for you is Palatine, ticker symbol PTN. Now who are they? So they're a buyer pharmaceutical company developing targeted receptor specific peptide for therapeutics for the treatment of diseases with significant unmedical needs and commercial potential, okay? This stock has got the potential to run up because again investors, institutional investors have been buying this stock recently, okay? Institutional investors are buying this stock. And what is it currently set at? It's at 0.96. The analysts on CNN business have this low of $2, a medium of $2 and a high of $3. So this has got a potential to run up 2 to 3x, okay? It really does from the current price point. I think that this could easily reach $1.70 to $2.40 around that range very, very quickly, very easily. I think that's in the short to medium term. This stock's going to run up even further. And I think that it has got potential to have a medium long-term hold for this stock. It seems like a very good stock as well. So look into that one. The last one I've got for you today is called Selector Biosciences, CLRB. So they're a clinical stage biopharmaceutical company focused on the discovery, development and commercialisation of drugs for the treatment of cancer. So they're involved in this area. They take a symbol of CLRB. And the current price for this is $1.92, okay? And the analysts, the five analysts here on CNN have a low of $3, a medium of $5.50 and a high of $10. I think that this stock, again, is going to reach sort of free for $5 within the short to medium term. I think it's got a lot of time that it's going to run up. It's on a bit of a dip. I think if you get this stock anywhere below $1.90 or around this level, $1.92 is quite a decent price as well. Get this, establish a position for the run-up that's going to happen for this stock or that I believe is going to happen, okay? I really do believe this stock is going to run up from this current price point. It did have a recent direct offering, which is why the stock went down from like $2.70, $2.80 down to this sort of level. But I think it's going to shoot back up again eventually, okay? And beyond that as well. So that's the one that I've got for you today. So thanks for watching this top five list and don't forget to turn on notifications for any penny stock alerts that I post out there. So you're first-hand getting the information, especially if the market's open at the time I make the video, et cetera. You get first-hand information then. Okay, thank you for watching and I'll see everybody in the next one.